The Neglected Contribution of Streptomycin to the Tuberculosis Drug Resistance Problem.

Drug Resistance, Microbial / drug effects Genotype Humans Microbial Sensitivity Tests Mutation Mycobacterium tuberculosis / genetics Streptomycin / pharmacology Tuberculosis / drug therapy Tuberculosis, Multidrug-Resistant / drug therapy
Mycobacterium antibiotic drug-resistance lineages multidrug-resistance mutations resistance level streptomycin tuberculosis

Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
17 12 2021
Historique:
received: 16 10 2021
revised: 14 12 2021
accepted: 15 12 2021
entrez: 24 12 2021
pubmed: 25 12 2021
medline: 16 2 2022
Statut: epublish

Résumé

The airborne pathogen

Identifiants

DOI: 10.3390/genes12122003 PMID: 34946952 PMC: PMC8701281
pubmed: 34946952
pii: genes12122003
doi: 10.3390/genes12122003
pmc: PMC8701281
pii:
doi:

Substances chimiques

Streptomycin Y45QSO73OB

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

PLoS One. 2014 Jun 17;9(6):e100078
pubmed: 24937123
Front Microbiol. 2017 Feb 17;8:246
pubmed: 28261193
Nat Commun. 2019 Jul 2;10(1):2928
pubmed: 31266959
Front Cell Infect Microbiol. 2019 Nov 05;9:345
pubmed: 31828045
Front Microbiol. 2020 Sep 17;11:559469
pubmed: 33042066
Proc Natl Acad Sci U S A. 2019 Sep 24;116(39):19665-19674
pubmed: 31488707
PLoS One. 2012;7(8):e42323
pubmed: 22912700
Antibiotics (Basel). 2021 Sep 26;10(10):
pubmed: 34680750
FEMS Microbiol Rev. 2017 May 1;41(3):354-373
pubmed: 28369307
Eur Respir J. 2017 Mar 22;49(3):
pubmed: 28331043
Infect Drug Resist. 2018 Mar 27;11:431-440
pubmed: 29628767
Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):3910-3912
pubmed: 32075922
Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):3913-3914
pubmed: 32075921
mBio. 2019 Jul 30;10(4):
pubmed: 31363023
Mol Biol Evol. 2020 Jan 1;37(1):195-207
pubmed: 31532481
Antimicrob Agents Chemother. 2020 Aug 20;64(9):
pubmed: 32540971
Antimicrob Agents Chemother. 2013 Apr;57(4):1857-65
pubmed: 23380727
Trends Microbiol. 2018 Aug;26(8):677-691
pubmed: 29439838
Molecules. 2019 Mar 03;24(5):
pubmed: 30832456
Nat Genet. 2016 May;48(5):544-51
pubmed: 27064254
J Glob Antimicrob Resist. 2016 Mar;4:5-10
pubmed: 27436385
J Clin Microbiol. 2011 Jul;49(7):2625-30
pubmed: 21593257
Antimicrob Agents Chemother. 2020 Sep 21;64(10):
pubmed: 32718966
EcoSal Plus. 2018 Nov;8(1):
pubmed: 30447062
Nature. 2000 Sep 21;407(6802):327-39
pubmed: 11014182
J Drug Target. 2019 Nov;27(9):1004-1016
pubmed: 30730218
Tuberculosis (Edinb). 2018 Jul;111:8-13
pubmed: 30029920
ERJ Open Res. 2020 Aug 31;6(3):
pubmed: 32904577
Epidemics. 2021 Sep;36:100471
pubmed: 34256273
Nat Commun. 2015 May 11;6:7119
pubmed: 25960343
SLAS Discov. 2017 Dec;22(10):1229-1238
pubmed: 28314116
mBio. 2018 May 15;9(3):
pubmed: 29764951
Int J Med Microbiol. 2019 Dec;309(8):151353
pubmed: 31521502
FEMS Microbiol Rev. 2021 Aug 17;45(4):
pubmed: 33320947
J Proteome Res. 2016 Apr 1;15(4):1194-204
pubmed: 26930559
PLoS One. 2019 Jun 12;14(6):e0217597
pubmed: 31188848
Mol Microbiol. 2007 Feb;63(4):1096-106
pubmed: 17238915
PLoS One. 2018 Jun 4;13(6):e0197737
pubmed: 29864118
Medchemcomm. 2019 Jun 11;10(8):1342-1360
pubmed: 31534654
Int J Infect Dis. 2017 Mar;56:200-207
pubmed: 28007659
Tuberculosis (Edinb). 2021 Jul;129:102092
pubmed: 34102584
Tuberculosis (Edinb). 2021 Jul;129:102091
pubmed: 34090078
J Infect. 2000 Sep;41(2):184-7
pubmed: 11023769
Mol Microbiol. 1993 Sep;9(6):1239-46
pubmed: 7934937
PLoS One. 2020 Dec 31;15(12):e0244829
pubmed: 33382836
Antimicrob Agents Chemother. 2006 Aug;50(8):2836-41
pubmed: 16870781
Front Cell Infect Microbiol. 2020 Aug 25;10:443
pubmed: 32984071
J Glob Antimicrob Resist. 2019 Dec;19:301-307
pubmed: 31100498
Sci Rep. 2020 May 15;10(1):8024
pubmed: 32415151
Microb Genom. 2018 Feb;4(2):
pubmed: 29310751
Evol Bioinform Online. 2020 Jul 27;16:1176934320944932
pubmed: 32782426
PLoS Med. 2015 Sep 29;12(9):e1001880
pubmed: 26418737
mBio. 2011 Jun 14;2(3):e00100-11
pubmed: 21673191
Tuberculosis (Edinb). 2016 Jan;96:102-6
pubmed: 26786661
Ann Am Thorac Soc. 2015 Dec;12(12):1749-59
pubmed: 26653188
J Biol Chem. 2012 Jan 2;287(1):299-310
pubmed: 22069311
Tuberculosis (Edinb). 2020 Dec;125:101985
pubmed: 32829153
PLoS One. 2019 Jun 5;14(6):e0213046
pubmed: 31166945
Comp Immunol Microbiol Infect Dis. 2021 Feb;74:101574
pubmed: 33249329
PLoS Negl Trop Dis. 2021 Apr 22;15(4):e0009324
pubmed: 33886558
BMC Infect Dis. 2020 Nov 11;20(1):831
pubmed: 33176701
Antimicrob Agents Chemother. 2004 Apr;48(4):1289-94
pubmed: 15047531
Nat Commun. 2020 Apr 3;11(1):1661
pubmed: 32245967
BMC Microbiol. 2020 May 25;20(1):132
pubmed: 32450809
Antimicrob Agents Chemother. 2020 Aug 20;64(9):
pubmed: 32540973
Lancet Microbe. 2021 Mar;2(3):e96-e104
pubmed: 33912853
mSystems. 2020 Dec 15;5(6):
pubmed: 33323416
Antimicrob Agents Chemother. 2019 Mar 27;63(4):
pubmed: 30718257
Lancet Infect Dis. 2012 Feb;12(2):157-66
pubmed: 22281142
Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0116421
pubmed: 34460306
Clin Infect Dis. 2015 Oct 15;61Suppl 3:S102-18
pubmed: 26409271
J Glob Antimicrob Resist. 2017 Jun;9:51-56
pubmed: 28404234
BMC Microbiol. 2012 May 30;12:90
pubmed: 22646308
PLoS One. 2016 Sep 16;11(9):e0162797
pubmed: 27636095
Nat Commun. 2020 Apr 23;11(1):1949
pubmed: 32327653
Antibiotics (Basel). 2021 Jul 02;10(7):
pubmed: 34356728
Tuberculosis (Edinb). 2018 May;110:44-51
pubmed: 29779772
Toxins (Basel). 2014 Mar 06;6(3):1002-20
pubmed: 24662523
J Antimicrob Chemother. 2013 Jan;68(1):27-33
pubmed: 23054995
Lancet Infect Dis. 2003 Jan;3(1):13-21
pubmed: 12505028
Science. 2006 Jun 30;312(5782):1944-6
pubmed: 16809538
Nat Genet. 2018 Jun;50(6):849-856
pubmed: 29785015
Bioinformation. 2019 Apr 15;15(4):261-268
pubmed: 31285643
Sci Rep. 2017 Jul 19;7(1):5868
pubmed: 28724903
Microb Drug Resist. 2020 Jul;26(7):766-775
pubmed: 31976809
Nat Microbiol. 2018 Sep;3(9):1032-1042
pubmed: 30082724
Clin Microbiol Rev. 2020 Oct 14;34(1):
pubmed: 33055230
PLoS One. 2012;7(3):e33275
pubmed: 22479378
Nat Genet. 2017 Mar;49(3):395-402
pubmed: 28092681
PLoS Biol. 2017 Apr 18;15(4):e2001741
pubmed: 28419091
Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2790-4
pubmed: 8610119
PLoS One. 2017 Mar 23;12(3):e0174197
pubmed: 28333978
Antibiotics (Basel). 2021 Jul 15;10(7):
pubmed: 34356778
World J Microbiol Biotechnol. 2013 Jun;29(6):975-82
pubmed: 23329063
Front Microbiol. 2021 Jun 11;12:659545
pubmed: 34177837
Mol Biotechnol. 2020 Jul;62(6-7):335-343
pubmed: 32236842
Lancet Respir Med. 2017 Mar 15;:
pubmed: 28344011
Lancet Infect Dis. 2018 Jul;18(7):779-787
pubmed: 29685458
Curr Microbiol. 2005 Sep;51(3):141-7
pubmed: 16091848
BMC Infect Dis. 2018 Apr 2;18(1):149
pubmed: 29606091
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 28993339
Nature. 2000 Sep 21;407(6802):340-8
pubmed: 11014183
Eur Respir J. 2017 Dec 28;50(6):
pubmed: 29284687
Antimicrob Agents Chemother. 1995 Mar;39(3):769-70
pubmed: 7540819
Expert Opin Investig Drugs. 2003 Aug;12(8):1297-312
pubmed: 12882618
J Chemother. 2017 Feb;29(1):14-18
pubmed: 27380108
Trop Med Infect Dis. 2020 Sep 30;5(4):
pubmed: 33007895
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13206-11
pubmed: 21788497
Clin Microbiol Infect. 2014 May;20(5):O278-84
pubmed: 24102832

Auteurs

Deisy M G C Rocha (DMGC)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus Gualtar, 4710-057 Braga, Portugal.
ICVS/3B's, PT Government Associate Laboratory, 4710-057 Braga, Portugal.
i3S, Instituto de Investigacão e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.
IBMC, Instituto de Biologia Molecular e Celular, University of Porto, 4200-135 Porto, Portugal.

Miguel Viveiros (M)

GHTM, Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical da Universidade NOVA de Lisboa, 1349-008 Lisboa, Portugal.
ORCID: 0000-0001-9676-6251

Margarida Saraiva (M)

i3S, Instituto de Investigacão e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.
IBMC, Instituto de Biologia Molecular e Celular, University of Porto, 4200-135 Porto, Portugal.

Nuno S Osório (NS)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus Gualtar, 4710-057 Braga, Portugal.
ICVS/3B's, PT Government Associate Laboratory, 4710-057 Braga, Portugal.
ORCID: 0000-0003-0949-5399

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › The Neglected Contribution of Streptomycin to...
questionsmedicales.fr › Phénomènes génétiques › Génotype › The Neglected Contribution of Streptomycin to...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The Neglected Contribution of Streptomycin to...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › The Neglected Contribution of Streptomycin to...
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Mutation › The Neglected Contribution of Streptomycin to...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Bâtonnets à Gram positif › Bâtonnets asporogènes à Gram positif › Bâtonnets asporogènes réguliers à Gram positif › Mycobacteriaceae › Mycobacterium › Mycobacterium tuberculosis › The Neglected Contribution of Streptomycin to...
questionsmedicales.fr › Glucides › Hétérosides › Aminosides › Streptomycine › The Neglected Contribution of Streptomycin to...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › Infections à Actinomycetales › Infections à Mycobacterium › Tuberculose › The Neglected Contribution of Streptomycin to...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › Infections à Actinomycetales › Infections à Mycobacterium › Tuberculose › Tuberculose multirésistante › The Neglected Contribution of Streptomycin to...